1. Home
  2. ALEC vs DMF Comparison

ALEC vs DMF Comparison

Compare ALEC & DMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALEC
  • DMF
  • Stock Information
  • Founded
  • ALEC 2013
  • DMF 1988
  • Country
  • ALEC United States
  • DMF United States
  • Employees
  • ALEC N/A
  • DMF N/A
  • Industry
  • ALEC Biotechnology: Biological Products (No Diagnostic Substances)
  • DMF Finance/Investors Services
  • Sector
  • ALEC Health Care
  • DMF Finance
  • Exchange
  • ALEC Nasdaq
  • DMF Nasdaq
  • Market Cap
  • ALEC 124.0M
  • DMF 143.6M
  • IPO Year
  • ALEC 2019
  • DMF N/A
  • Fundamental
  • Price
  • ALEC $1.47
  • DMF $6.93
  • Analyst Decision
  • ALEC Buy
  • DMF
  • Analyst Count
  • ALEC 7
  • DMF 0
  • Target Price
  • ALEC $4.70
  • DMF N/A
  • AVG Volume (30 Days)
  • ALEC 679.0K
  • DMF 60.7K
  • Earning Date
  • ALEC 08-06-2025
  • DMF 01-01-0001
  • Dividend Yield
  • ALEC N/A
  • DMF 2.66%
  • EPS Growth
  • ALEC N/A
  • DMF N/A
  • EPS
  • ALEC N/A
  • DMF 0.15
  • Revenue
  • ALEC $88,339,000.00
  • DMF N/A
  • Revenue This Year
  • ALEC N/A
  • DMF N/A
  • Revenue Next Year
  • ALEC $319.82
  • DMF N/A
  • P/E Ratio
  • ALEC N/A
  • DMF $45.13
  • Revenue Growth
  • ALEC N/A
  • DMF N/A
  • 52 Week Low
  • ALEC $0.87
  • DMF $5.37
  • 52 Week High
  • ALEC $6.78
  • DMF $6.79
  • Technical
  • Relative Strength Index (RSI)
  • ALEC 53.71
  • DMF 45.82
  • Support Level
  • ALEC $1.37
  • DMF $6.86
  • Resistance Level
  • ALEC $1.62
  • DMF $6.97
  • Average True Range (ATR)
  • ALEC 0.13
  • DMF 0.05
  • MACD
  • ALEC -0.01
  • DMF 0.00
  • Stochastic Oscillator
  • ALEC 46.34
  • DMF 61.04

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

About DMF BNY Mellon Municipal Income Inc.

BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.

Share on Social Networks: